Lesiones gastrointestinales en pacientes con enfermedad renal crónica y anemia

Hsu, 2002, Epidemiology of anemia associated with chronic renal insufficiency among adults in the United Status: Results from the Third Nacional Health and Nutrition Examination Survey, J Am Soc Nephrol, 13, 504, 10.1681/ASN.V132504 Araki, 1999, Significance of serum pepsinogens and their relationship to Helicobacter pylori infection and histological gastritis in dialysis patients, Nephrol Dial Transplant, 14, 2669, 10.1093/ndt/14.11.2669 Sotoudehmanesh, 2003, Endoscopic findings in end-stage renal disease, Endoscopy, 35, 502, 10.1055/s-2003-39672 Tamura, 1997, Eradication of Helicobacter pylori in patients with end-stage renal disease under dialysis treatment, Am J Kidney Dis, 29, 86, 10.1016/S0272-6386(97)90012-3 Gür, 1999, Impact of Helicobacter pylori infection on serum gastrin in haemodialysis patients, Nephrol Dial Transplant, 14, 2688, 10.1093/ndt/14.11.2688 Zuckerman, 1985, Upper gastrointestinal bleeding in patients with chronic renal failure, Ann Intern Med, 102, 588, 10.7326/0003-4819-102-5-588 Nardone, 2005, Gastroduodenal lesions and Helicobacter pylori infection in dyspeptic patients with and without chronic renal failure, Helicobacter, 10, 53, 10.1111/j.1523-5378.2005.00291.x Scheff, 1980, Diverticular disease in patients with chronic renal failure due to polycystic kidney disease, Ann Intern Med, 92, 202, 10.7326/0003-4819-92-2-202 Khedmat, 2007, Gastro-duodenal lesions and Helicobacter pylori infection in uremic patients and renal transplant recipients, Transplant Proc, 39, 1003, 10.1016/j.transproceed.2007.03.034 Al-Mueilo, 2004, Gastroduodenal lesions and Helicobacter pylori infection in hemodialysis patients, Saudi Med J, 25, 1010 Inamoto, 1991, Incidence and mortality patterns of malignancy and factors affecting the risk of malignancy in dialysis patients, Nephron, 59, 611, 10.1159/000186652 Iseki, 1993, Evidence for increased cáncer deaths in chronic dialysis patients, Am J Kidney Dis, 22, 308, 10.1016/S0272-6386(12)70323-2 Ferlay, 2015, Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012, Int J Cancer, 136, E359, 10.1002/ijc.29210 WHO. International Agency for Research on cancer. GLOBALCAN 2012: Estimated cancer incidence, mortality and prevalence Worldwide in 2012 [consultado 10 Sep 2017]. Disponible en: http://globocan.iarc.fr/Default.aspx Rodés, 2007, Libro de la salud del Hospital Clínic de Barcelona y la Fundación BBVA, Fundación BBVA, 323 Winawer, 2003, Colorectal cancer screening and surveillance: Clinical guidelines and rationale-Update based on new evidence, Gastroenterology, 124, 544, 10.1053/gast.2003.50044 Young, 2002, Choice of fecal occult blood tests for colorectal cancer screening: Recommendations based on performance characteristics in populations studies: A WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report, Am J Gastroenterol, 97, 2499 Morikawa, 2005, A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population, Gastroenterology, 129, 422, 10.1016/j.gastro.2005.05.056 Songster, 1980, Immunochemical detection of fecal occult blood the fecal smear punch-disc test: A new none invasive screening test for colorrectal cancer, Cancer, 45, 1099, 10.1002/1097-0142(19800315)45:5+<1099::AID-CNCR2820451312>3.0.CO;2-T KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease. Kidney Int Supplements 2012; 308. López Gómez, 2008, Management of anemia in chronic kidney disease, Nefrologia, 28, S63 Locatelli, 2004, Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure, Nephrol Dial Transpl, 19, ii1 NKF-DOQI Clinical Practice Guidelines for the treatment of anemia of chronic renal failure. Am J Kidney Dis. 1997;30 Suppl 3:S192-240. Levey, 2003, National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification, Ann Intern Med, 139, 137, 10.7326/0003-4819-139-2-200307150-00013 KDOQI. KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis. 2007;50:471-530. Chronic kidney disease: managing anaemia. NICE guideline (2015) [consultado 10 Sep 2017]. Disponible en: http://nice.org.uk/guidance/ng8 Launoy, 2005, Evaluation of an immunochemical fecal occult blood test with automated reading in screening for colorectal cancer in a general average-risk population, Int J Cancer, 115, 493, 10.1002/ijc.20921 Bini, 2006, Predictive value of a positive fecal occult blood test increases as the severity of CKD worsens, Am J Kidney Dis, 48, 580, 10.1053/j.ajkd.2006.07.002 Lee, 2008, The prevalence of colorectal neoplasia in patients with end-stage renal disease: A case-control study, Int J Colorectal Dis, 23, 47, 10.1007/s00384-007-0379-7 Zuckerman, 1985, Upper gastrointestinal bleeding in patients with chronic renal failure, Ann Intern Med, 102, 588, 10.7326/0003-4819-102-5-588 Vamvakas, 1998, Cancer in end-stage renal disease: Potential factors involved, Am J Nephrol, 18, 89, 10.1159/000013314 Wu, 2013, Risk of colorectal cancer in chronic kidney disease: A matched cohort study based on administrative data, Ann Surg Oncol, 20, 3885, 10.1245/s10434-013-3065-8 Ito, 1999, Screening for gastroenterological malignancies in new and maintenance dialysis patients, J Gastroenterol, 34, 35, 10.1007/s005350050213 Las cifras del cáncer en España. Sociedad Española de Oncología Médica (2017) [consultado 10 Sep 2017]. Disponible en: https://www.seom.org/seomcms/images/stories/recursos/Las_cifras_del_cancer_en_Esp_2017.pdf